Moderna Inc. stock outperforms market on strong trading day

This post was originally published on this site

© Terrence Horan


Shares of Moderna Inc. MRNA rose 3.05% to $174.74 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.07% to 13,874.46 and the Dow Jones Industrial Average DJIA rising 0.00% to 31,494.32. The stock’s rise snapped a three-day losing streak. Moderna Inc. closed $14.52 short of its 52-week high ($189.26), which the company reached on February 8th.

The stock outperformed some of its competitors Friday, as AbbVie Inc. ABBV fell 0.99% to $105.01, Amgen Inc. AMGN fell 0.36% to $231.69, and AstraZeneca PLC ADR AZN fell 1.77% to $50.59. Trading volume (6.4 M) remained 12.7 million below its 50-day average volume of 19.0 M.

Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading